References
- Flora A, Kozera E, Frew JW. Treatment of alopecia areata with the janus kinase inhibitor upadacitinib: a retrospective cohort study. J Am Acad Dermatol. 2023;89(1):1–3. doi: 10.1016/j.jaad.2022.12.056.
- Gori N, Cappilli S, Di Stefani A, et al. Assessment of alopecia areata universalis successfully treated with upadacitinib. Int J Dermatol. 2023;62(2):e61–e63. doi: 10.1111/ijd.16342.
- Novielli D, Foti C, Principi M, et al. Upadacitinib in concurrent Crohn’s disease, atopic dermatitis and alopecia areata: a case report. J Eur Acad Dermatol Venereol. 2023;38(1):e8–e10. doi: 10.1111/jdv.19377.
- Johnston LA, Lu C, Poelman SM. Successful treatment of concomitant alopecia universalis and Crohn’s disease with upadacitinib: a case report. SAGE Open Med Case Rep. 2023;11:2050313X231160914.
- Uchida H, Kamata M, Watanabe A, et al. Improvement of severe alopecia areata after 9-month baricitinib treatment followed by subsequent use of upadacitinib in a patient with atopic dermatitis. J Dermatol. 2023;50:e392–e393.
- Youssef S, Bordone LA. Effective treatment of alopecia universalis with oral upadacitinib. JAAD Case Rep. 2023;31:80–82. doi: 10.1016/j.jdcr.2022.08.014.
- Chiricozzi A, Balato A, Fabbrocini G, et al. Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: a multicenter retrospective study. J Am Acad Dermatol. 2023;89(6):1251–1253.
- Asfour L, Getsos Colla T, Moussa A, et al. Concurrent chronic alopecia areata and severe atopic dermatitis successfully treated with upadacitinib. Int J Dermatol. 2022;61(11):e416–e417. doi: 10.1111/ijd.16316.
- Kwon O, Senna MM, Sinclair R, et al. Efficacy and safety of baricitinib in patients with severe alopecia areata over 52 weeks of continuous therapy in two phase III trials (BRAVE-AA1 and BRAVE-AA2). Am J Clin Dermatol. 2023;24(3):443–451. doi: 10.1007/s40257-023-00764-w.
- AbbVie. A phase 3 randomized, placebo-controlled, double-blind program to evaluate efficacy and safety of upadacitinib in adult and adolescent subjects with severe alopecia areata [Internet]. 2023 Dec [cited 2023 Jan 1]. Report No.: NCT06012240. Available from: https://clinicaltrials.gov/study/NCT06012240